Category Archives: TB

What we’re reading: Ways to track progress toward TB goals

By on .

Combatting MDR TB: Year three – Released four years ago, the federal National Action Plan for Combating Multidrug-Resistant Tuberculosis raised hopes that targets and strategies would raise awareness of the resources needed to stem the spread of the hardest to treat forms of TB. The plan which emphasized expanded diagnosis and treatment access, also raised […]

WHO recommends expanded access to new, shorter, all oral regimens for drug-resistant TB

By on .

Incorporating patient data from national TB programs and from ongoing research, the World Health Organization has updated its guidelines on treatment for drug-resistant tuberculosis with an emphasis on accelerating access to more effective regimens that eliminate the inclusion of toxic painful injections. Among the data leading to the updated recommendation, released in a WHO Rapid […]

50th Union World Conference on Lung Health: Vaccine candidate shows effectiveness in preventing active TB disease

By on .

HYDERABAD, INDIA – The world is one major step closer to a vaccine against tuberculosis, researchers said here, with results from a clinical trial of an investigational candidate showing 50% efficacy in preventing latent TB infection from progressing to active TB disease that was sustained three years after the start of the study. “We have […]

WHO TB 2019 report: Unprecedented political commitment leads to unprecedented progress

By on .

But with a $3.3 billion shortfall in funding, gaps in treatment and prevention among the most vulnerable still take 4,000 lives a day For the first time, political commitment “at the highest level” has joined against the world’s deadliest infectious disease, the World Health Organization’s tuberculosis response leader noted today, unveiling the agency’s 2019 Global […]

China study supports use of repurposed drug, shorter regimen for MDR TB treatment

By on .

Patients treated for multidrug-resistant tuberculosis with an experimental regimen containing a repurposed drug for a year had similar rates of successful outcomes as patients treated with the standard available regimen over the course of 18 months, a study across multiple health facilities in China has found. The only significant difference between the outcomes of the […]

New TB drug approval a milestone, all agree — with caveats, some add

By on .

The announcement Wednesday of U.S. Food and Drug Administration approval of pretomanid, a new tuberculosis drug that has been part of a ground-breaking treatment regimen against the deadliest and most resistant form of the disease represented a major step forward on multiple fronts, international treatment advocates agree. One of only three new drugs receiving regulatory […]

Activist confronts the “father” of drug-resistant TB

By on .

The following is a guest post by Abigail Mudd, MPH A human rights lawyer and two-time tuberculosis survivor, Timur Abdullaev is an international TB activist. He owes his life, he says, to treatment supported by the Global Fund to Fight AIDS, Tuberculosis and Malaria, and now he also depends on the multilateral initiative for his […]

IAS 2019: Preventing TB — the leading killer of people with HIV — remains tangential to global HIV responses

By on .

MEXICO CITY – In a day-long, pre-conference meeting devoted to addressing tuberculosis prevention among people living with HIV, which continues to account for one in three HIV-related deaths globally, experts discussed the urgent need to listen to communities about their TB prevention needs and offer people-centered interventions. This includes integrating TB prevention services at family planning […]

Global Health Security 2019: Unmet needs increase worldwide threat of drug-resistant TB

By on .

SYDNEY – When Merinda Sebayang was undergoing treatment for multidrug-resistant TB in Indonesia – a nation with the third highest tuberculosis burden in the world after India and China – she would wonder about the tens of thousands of people living in poverty who couldn’t afford enough food for TB treatment to work, she said […]

Thinking strategically about nutrition supports disease responses and more

By on .

The following is a guest post by Heather B. Davis, MPH, and Emily A. Bobrow, PhD, MPH, of MEASURE Evaluation Who has a strategic interest in nutrition? Is the world on course to meet global nutrition targets? What does it mean to have a robust national dialogue to support the development of practical nutrition solutions? […]